UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of chemotherapy near the end of life: what factors matter?

Annals of oncology, 2017-04, Vol.28 (4), p.809-817

2017

Volltextzugriff (PDF)

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Annals of oncology, 2017-09, Vol.28 (9), p.2149-2159

2017

Volltextzugriff (PDF)

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

European journal of cancer (1990), 2013-01, Vol.49 (1), p.90-97

2013

Volltextzugriff (PDF)

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S85-S86

2017

Volltextzugriff (PDF)

6569 POSTER Updated Overall Survival Data From a Phase III Study of Sunltlnlb Vs. Placebo in Patients With Advanced, Unresectable Pancreatic Neuroendocrine Tumour (NET)

European journal of cancer (1990), 2011, Vol.47, p.S462-S462

2011

Volltextzugriff (PDF)

Use of chemotherapy near the end of life for solid cancers: What factors matter?

Annals of oncology, 2016-10, Vol.27, p.vi455-vi455

2016

Volltextzugriff (PDF)

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

Journal of hepatology, 2009, Vol.50, p.S28-S29

2009

Volltextzugriff (PDF)

Medical oncologists must get more involved in systemic treatment

Annals of oncology, 2019-01, Vol.30 (1), p.6-8

2019

Volltextzugriff (PDF)

Glutathione-S-Transferases (GST) Activity Decreases Survival in Chemoradiotherapy for Esophageal Cancer

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S270-S270

2008

Volltextzugriff (PDF)

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Digestive and liver disease, 2023-12, Vol.55 (12), p.1583-1601

2023

Volltextzugriff (PDF)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

ESMO open, 2023-02, Vol.8 (1), p.100880-100880, Article 100880

2023

Volltextzugriff (PDF)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

European journal of cancer (1990), 2018-11, Vol.104, p.108-116

2018

Volltextzugriff (PDF)

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

Annals of oncology, 2008-06, Vol.19 (6), p.1117-1126

2008

Volltextzugriff (PDF)

3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

European journal of cancer supplements, 2007-09, Vol.5 (4), p.235-235

2007

Volltextzugriff (PDF)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

Annals of oncology, 2017-09, Vol.28, p.v171-v171

2017

Volltextzugriff (PDF)

P-037 Advanced Pancreatic Cancer Patients' Characteristics, Treatment and Outcome Based on Three Age Groups: ≤ 39, 39-74 and ≥ 75, a Report from Single Cancer Institution

Annals of oncology, 2015-06, Vol.26, p.iv10

2015

Volltextzugriff (PDF)

GS-012 - SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S85-S86

2017

Volltextzugriff (PDF)

Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting

Journal of hepatology, 2011-01, Vol.54 (1), p.108-114

2011

Volltextzugriff (PDF)

6501 Sunitinib (SU) vs placebo for treatment of progressive, well- differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

European journal of cancer supplements, 2009, Vol.7 (2), p.361-361

2009

Volltextzugriff (PDF)

PTK7 Overexpression is Associated with Reduced Metastasis-Free Survival (MFS) in Colorectal Cancer

Annals of oncology, 2012-09, Vol.23, p.ix184

2012

Volltextzugriff (PDF)

Comparison in 1323 Patients of Preoperative Imaging Staging and Pathological Examination of Resected Pancreatic Head Adenocarcinoma: Series of the Association Française De Chirurgie

Annals of oncology, 2012-09, Vol.23, p.ix241

2012

Volltextzugriff (PDF)

539P - PTK7 Overexpression is Associated with Reduced Metastasis-Free Survival (MFS) in Colorectal Cancer

Annals of oncology, 2012-09, Vol.23, p.ix184-ix184

2012

Volltextzugriff (PDF)

A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study

Annals of oncology, 2014-06, Vol.25, p.ii7-ii7

2014

Volltextzugriff (PDF)

Quality of Life as a Prognostic Factor of Overall Survival in Patients with Advanced Hepatocellular Carcinoma: Results from Two French Clinical Trials

Quality of life research, 2008-08, Vol.17 (6), p.831-843

2008

Volltextzugriff (PDF)

Updated Overall Survival (OS) Analysis from a Phase III Study of Sunitinib vs Placebo in Patients (PTS) with Advanced, Unresectable Pancreatic Neuroendocrine Tumor (NET)

Annals of oncology, 2012-09, Vol.23, p.ix376

2012

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)
Tagungsberichte
(1)

Sprache

Englisch
(72)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(35)
Humans
(26)
Male
(19)
Female
(18)
Biological And Medical Sciences
(14)
Middle Aged
(14)
Adult
(13)
Aged
(13)
Life Sciences
(11)
Medical Sciences
(9)
Aged, 80 And Over
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Isotopes
(6)
Oncology
(6)
Tumors
(6)
Beta Decay Radioisotopes
(5)
Body
(5)
Cancer
(5)
Days Living Radioisotopes
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of chemotherapy near the end of life: what factors matter?

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

6569 POSTER Updated Overall Survival Data From a Phase III Study of Sunltlnlb Vs. Placebo in Patients With Advanced, Unresectable Pancreatic Neuroendocrine Tumour (NET)

Use of chemotherapy near the end of life for solid cancers: What factors matter?

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

Medical oncologists must get more involved in systemic treatment

Glutathione-S-Transferases (GST) Activity Decreases Survival in Chemoradiotherapy for Esophageal Cancer

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

P-037 Advanced Pancreatic Cancer Patients' Characteristics, Treatment and Outcome Based on Three Age Groups: ≤ 39, 39-74 and ≥ 75, a Report from Single Cancer Institution

GS-012 - SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting

6501 Sunitinib (SU) vs placebo for treatment of progressive, well- differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

PTK7 Overexpression is Associated with Reduced Metastasis-Free Survival (MFS) in Colorectal Cancer

Comparison in 1323 Patients of Preoperative Imaging Staging and Pathological Examination of Resected Pancreatic Head Adenocarcinoma: Series of the Association Française De Chirurgie

539P - PTK7 Overexpression is Associated with Reduced Metastasis-Free Survival (MFS) in Colorectal Cancer

A Triple Combination Tailored Therapy (Folfiri-Cetuximab) for Safe Dose Intensification: A Multicenter Phase II Proof-Of-Concept Study

Quality of Life as a Prognostic Factor of Overall Survival in Patients with Advanced Hepatocellular Carcinoma: Results from Two French Clinical Trials

Updated Overall Survival (OS) Analysis from a Phase III Study of Sunitinib vs Placebo in Patients (PTS) with Advanced, Unresectable Pancreatic Neuroendocrine Tumor (NET)

Suchergebnisse filtern